Nevertheless, the success of various biological therapies (in particular, of anti-TNF alpha) in changing the natural history of rheumatological diseases does not necessarily imply their effectiveness in changing the natural history of IBD, where evidence showing a clear reduction in surgery for complications is lacking [44]. This evidence concerns the gene TNF and inflammatory bowel disease.